SCHEMBL8291442

SCHEMBL8291442

CN(C)C(=O)[C@@H](NC(=O)CNC(=O)C(=O)[C@@H]1CCCCCCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N2C[C@H](CNC(=O)OCc3ccccc3)C[C@H]2C(=O)N1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.36
▸ BACE1 P56817 2/20 0.35
▸ ELANE P08246 2/20 0.35
▸ CYP3A4 P08684 5/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ REN P00797 1/20 0.33
▸ OPRK1 P41145 2/20 0.33
▸ TERF2 Q15554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12856044 0.89 CYP3A4 (0.36) ELANECYP3A4ALDH1A1TSHROPRK1
SCHEMBL13685696 0.87 ELANE (0.37) BACE1ELANERENTERF2
SCHEMBL13685619 0.86 TERF2 (0.40) BACE1ELANETERF2
SCHEMBL16349612 0.84 CASP3 (0.41) CASP3BACE1CYP3A4ALDH1A1TSHR
SCHEMBL13685703 0.84 CASP3 (0.40) CASP3BACE1CYP3A4ALDH1A1TSHR
SCHEMBL13685011 0.81 BACE1 (0.36) BACE1ELANERENTERF2
SCHEMBL13685129 0.81 BACE1 (0.36) BACE1ELANERENTERF2
SCHEMBL13686171 0.81 BACE1 (0.36) BACE1ELANERENTERF2
SCHEMBL13685117 0.80 BACE1 (0.35) BACE1ELANECYP3A4ALDH1A1REN
SCHEMBL8291188 0.80 BACE1 (0.35) BACE1ELANECYP3A4ALDH1A1REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 — — WO disclosed
Send feedback